Lab Automation Advisory · Est. 2026

The lab is not a collection of instruments. It is a living system.

Systemic Automation Strategy advises executives in life science, biotech, and clinical diagnostics on what to automate, when to scale, and how to maximize return on every dollar of capital deployed in the lab.

Abstract illustration of a connected laboratory automation ecosystem
Case context
Genomics workcell, 35K samples, <3 months
250M+
Samples processed
$100M+
Annual CapEx / OpEx budgets directed
500,000+ sq ft
Clinical lab space designed
$870M
Deal anchored by the workflow we built
The Practice

Four engagements. One systemic view.

Every engagement begins with how data flows from LIMS through liquid handlers, into analytical instruments, and back out to the cloud.

Explore services →
01

Automation Roadmap

A defensible 24–36 month plan tied to revenue, capacity, and regulatory milestones — not a wish-list of instruments.

02

Workcell Architecture

End-to-end design from sample accessioning through LIMS, liquid handlers, analytical instruments, and data return — with AI integration across scheduling, middleware, and instruments.

03

Scale & Validation

Method validation, analytical verification, and clinical validation under the V-Model — built for FDA, CLIA, and CAP scrutiny.

04

Operational Excellence

AI-driven uptime, predictive maintenance, COGS reduction, and capacity forecasting grounded in robust data and infrastructure that protect first-pass rate at scale.

Abstract illustration of interconnected laboratory systems and data flow
Point of view

Most labs accumulate robotic islands. The instruments work — but the workflow doesn't. We architect the connective tissue: the schedulers, the data contracts, the service models, and the leadership cadence that make automation behave like a single instrument.

Built on two decades operating automation through IPO, FDA PMA, CLIA/CAP, SPAC, and acquisition — at Freenome, CareDx, Invitae, Complete Genomics, Codexis, Pacific Biosciences, and Applied Biosystems.
Sectors Served

Where we operate.

Clinical Diagnostics
IVD, LDT, and CLIA-scaled workflows under FDA, CLIA, and CAP.
Genomics & Liquid Biopsy
NGS library prep, ctDNA, multi-omics, sample-to-answer workcells.
Biotech R&D
Discovery, screening, and high-throughput assay platforms.
Life Science Operations
Capacity, COGS, CapEx planning, and lab footprint design.
Engagements are limited

If your board is asking what to automate next, start with a briefing.